ArcherDX
Acquired by Invitae
Is this your company?
Find the right fit for you - faster
Get tailored insights about working at ArcherDX in one quick step.
ArcherDX Snapshot
Archer’s mission is to democratize personalized medicine and decentralization of testing is fundamentally important to the success of personalized medicine because of the efficiencies and accuracies that are gained when testing is done locally.
ArcherDX, Inc. is a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine.
Using next-generation sequencing (NGS) technology, Archer® offers a robust platform for detecting variants associated with cancers and inherited diseases.
By using proprietary Anchored Multiplex PCR (AMP™) chemistry, Archer technology has robust detection capabilities for all variant types. Complemented by a suite of bioinformatics software, the Archer platform dramatically enhances complex variant identification and discovery.
ArcherDX provides oncology-focused research panels, formed by 4 product lines: FusionPlex®, VariantPlex®, LiquidPlex™ and Immunoverse™.
ArcherDX, Inc. is headquartered in Boulder, Colorado.
Using next-generation sequencing (NGS) technology, Archer® offers a robust platform for detecting variants associated with cancers and inherited diseases.
By using proprietary Anchored Multiplex PCR (AMP™) chemistry, Archer technology has robust detection capabilities for all variant types. Complemented by a suite of bioinformatics software, the Archer platform dramatically enhances complex variant identification and discovery.
ArcherDX provides oncology-focused research panels, formed by 4 product lines: FusionPlex®, VariantPlex®, LiquidPlex™ and Immunoverse™.
ArcherDX, Inc. is headquartered in Boulder, Colorado.
